Anna Gundlund1, Emil Loldrup Fosbøl2, Sunghee Kim3, Gregg C Fonarow4, Bernard J Gersh5, Peter R Kowey6, Elaine Hylek6, Kenneth W Mahaffey7, Laine Thomas3, Jonathan P Piccini3, Eric D Peterson3. 1. Department of Cardiology, University Hospital of Gentofte, Hellerup, Denmark. Electronic address: annagundlund@gmail.com. 2. Department of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Denmark. 3. Duke Clinical Research Institute, Durham, NC. 4. Ahmanson-UCLA Cardiomyopathy Center, Los Angeles, CA. 5. Mayo Clinic College of Medicine, Rochester, MN. 6. Boston University School of Medicine, Boston, MA. 7. Department of Medicine, Stanford University School of Medicine, Palo Alto, CA.
Abstract
BACKGROUND: We addressed whether patients with a family history of atrial fibrillation (AF) were diagnosed as having AF earlier in life, were more symptomatic, and had worse outcomes compared with those without a family history of AF. METHODS: Using the ORBIT-AF, we compared symptoms and disease characteristics in those with and without a family history of AF. A family history of AF was defined as AF in a first-degree family member and obtained by patient self-reporting. Multivariable Cox proportional hazard analyses were performed to compare the incidence of cardiovascular outcomes, AF progression, all-cause hospitalization, and all-cause death. RESULTS: Among 9,999 patients with AF from 176 US outpatient clinics, 1,481 (14.8%) had a family history of AF. Relative to those without, those with a family history of AF developed AF 5 years earlier on average (median age 65 vs 70 years, P < .01), with less comorbidity, and had more severe AF-related symptoms. No differences were found between the 2 groups in the risk of AF progression (adjusted hazard ratio [HR] 0.98, 95% CI 0.85-1.14), stroke, non-central nervous system embolism, or transient ischemic attack (adjusted HR 0.95, 95% CI 0.67-1.34), all-cause hospitalization (adjusted HR 1.03, 95% CI 0.94-1.12), and all-cause death (adjusted HR 1.05, 95% CI 0.86-1.27). CONCLUSIONS: Patients with a family history of AF developed AF at a younger age, had less comorbidity, and were more symptomatic. Once AF developed, no significantly increased risks of AF progression and thromboembolism were associated with a family history of AF compared with no family history.
BACKGROUND: We addressed whether patients with a family history of atrial fibrillation (AF) were diagnosed as having AF earlier in life, were more symptomatic, and had worse outcomes compared with those without a family history of AF. METHODS: Using the ORBIT-AF, we compared symptoms and disease characteristics in those with and without a family history of AF. A family history of AF was defined as AF in a first-degree family member and obtained by patient self-reporting. Multivariable Cox proportional hazard analyses were performed to compare the incidence of cardiovascular outcomes, AF progression, all-cause hospitalization, and all-cause death. RESULTS: Among 9,999 patients with AF from 176 US outpatient clinics, 1,481 (14.8%) had a family history of AF. Relative to those without, those with a family history of AF developed AF 5 years earlier on average (median age 65 vs 70 years, P < .01), with less comorbidity, and had more severe AF-related symptoms. No differences were found between the 2 groups in the risk of AF progression (adjusted hazard ratio [HR] 0.98, 95% CI 0.85-1.14), stroke, non-central nervous system embolism, or transient ischemic attack (adjusted HR 0.95, 95% CI 0.67-1.34), all-cause hospitalization (adjusted HR 1.03, 95% CI 0.94-1.12), and all-cause death (adjusted HR 1.05, 95% CI 0.86-1.27). CONCLUSIONS:Patients with a family history of AF developed AF at a younger age, had less comorbidity, and were more symptomatic. Once AF developed, no significantly increased risks of AF progression and thromboembolism were associated with a family history of AF compared with no family history.
Authors: M Benjamin Shoemaker; Daniela Husser; Carolina Roselli; Meelad Al Jazairi; Jonathan Chrispin; Michael Kühne; Benjamin Neumann; Stacey Knight; Han Sun; Sanghamitra Mohanty; Christian Shaffer; Sébastien Thériault; Lauren Lee Rinke; Joylene E Siland; Diane M Crawford; Laura Ueberham; Omeed Zardkoohi; Petra Büttner; Bastiaan Geelhoed; Steffen Blum; Stefanie Aeschbacher; Jonathan D Smith; David R Van Wagoner; Rebecca Freudling; Martina Müller-Nurasyid; Jay Montgomery; Zachary Yoneda; Quinn Wells; Tariq Issa; Peter Weeke; Victoria Jacobs; Isabelle C Van Gelder; Gerhard Hindricks; John Barnard; Hugh Calkins; Dawood Darbar; Greg Michaud; Stefan Kääb; Patrick Ellinor; Andrea Natale; Mina Chung; Saman Nazarian; Michael J Cutler; Moritz F Sinner; David Conen; Michiel Rienstra; Andreas Bollmann; Dan M Roden; Steven Lubitz Journal: Circ Arrhythm Electrophysiol Date: 2020-02-14
Authors: Keith A A Fox; Joseph E Lucas; Karen S Pieper; Jean-Pierre Bassand; A John Camm; David A Fitzmaurice; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Werner Hacke; Gloria Kayani; Ali Oto; Lorenzo G Mantovani; Frank Misselwitz; Jonathan P Piccini; Alexander G G Turpie; Freek W A Verheugt; Ajay K Kakkar Journal: BMJ Open Date: 2017-12-21 Impact factor: 2.692
Authors: Anna Gundlund; Jonas Bjerring Olesen; Laila Staerk; Christina Lee; Jonathan P Piccini; Eric D Peterson; Lars Køber; Christian Torp-Pedersen; Gunnar H Gislason; Emil Loldrup Fosbøl Journal: J Am Heart Assoc Date: 2016-11-19 Impact factor: 5.501
Authors: John Berntsson; Xinjun Li; Bengt Zöller; Andreas Martinsson; Pontus Andell; Steven A Lubitz; Gunnar Engström; Kristina Sundquist; J Gustav Smith Journal: J Am Heart Assoc Date: 2020-02-03 Impact factor: 5.501
Authors: Keith A A Fox; Saverio Virdone; Karen S Pieper; Jean-Pierre Bassand; A John Camm; David A Fitzmaurice; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Gloria Kayani; Ali Oto; Frank Misselwitz; Jonathan P Piccini; Frederik Dalgaard; Alexander G G Turpie; Freek W A Verheugt; Ajay K Kakkar Journal: Eur Heart J Qual Care Clin Outcomes Date: 2022-03-02